(Q39935533)

15 September 2017

E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer (English)

1 reference

15 September 2017

0 references

0 references

1 reference

K Fukuda

1

1 reference

15 September 2017

M Abei

2

1 reference

15 September 2017

H Ugai

3

1 reference

15 September 2017

R Kawashima

4

1 reference

15 September 2017

E Seo

5

1 reference

15 September 2017

M Wakayama

6

1 reference

15 September 2017

T Murata

7

1 reference

15 September 2017

S Endo

8

1 reference

15 September 2017

H Hamada

9

1 reference

15 September 2017

I Hyodo

10

1 reference

15 September 2017

K K Yokoyama

11

1 reference

15 September 2017

26 September 2008

1 reference

15 September 2017

1 reference

15 September 2017

16

1 reference

15 September 2017

2

1 reference

15 September 2017

126-136

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2008.67

15 September 2017

0 references

cites work

The National Cancer Data Base report on carcinoma of the gallbladder, 1989-1995.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Replication-selective oncolytic viruses in the treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

A novel E1A-E1B mutant adenovirus induces glioma regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Use of replicating oncolytic adenoviruses in combination therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Carcinoembryonic antigen (CEA) in benign and malignant epithelium of the gall bladder, extrahepatic bile ducts, and ampulla of Vater.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Complementary adenoviral vectors for oncolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Combination therapy with conditionally replicating adenovirus and replication defective adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Viral transactivating proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

The RB and p53 pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

Carcinoma of the gallbladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

7 January 2021

https://api.crossref.org/works/10.1038%2FCGT.2008.67

1 reference

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

7 January 2021

K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

7 January 2021

Transcriptional regulation of the carcinoembryonic antigen gene. Identification of regulatory elements and multiple nuclear factors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.67

7 January 2021

Identifiers

DOI

10.1038/CGT.2008.67

1 reference

15 September 2017

1 reference